Serotonin synthesis rate and the tryptophan hydroxylase-2: G-703T polymorphism in social anxiety disorder

Journal of Psychopharmacology

Volumn 30, Issue 10, 2016, Pages 1028-1035

  Furmark, Tomas ^a   Marteinsdottir, Ina ^b   Frick, Andreas ^a   Heurling, Kerstin ^a   Tillfors, Maria ^c   Appel, Lieuwe ^a   Antoni, Gunnar ^a   Hartvig, Per ^d   Fischer, Håkan ^e   Långström, Bengt ^a,f   Eriksson, Elias ^g   Fredrikson, Mats ^a,h  

^a UPPSALA UNIVERSITY   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

^c ÖREBRO UNIVERSITY   (Sweden)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e STOCKHOLM UNIVERSITY   (Sweden)

^f ODENSE UNIVERSITY HOSPITAL   (Denmark)

^g UNIVERSITY OF GOTHENBURG   (Sweden)

^h KAROLINSKA INSTITUTE   (Sweden)

Author keywords

anxiety; brain; gene; positron emission tomography; Serotonin synthesis; 11C 5 HTP

Indexed keywords

5 HYDROXYTRYPTOPHAN; CARBON 11; CARBOXYLYASE; GUANINE; SEROTONIN; THYMINE; TRYPTOPHAN HYDROXYLASE 2; TPH2 PROTEIN, HUMAN; TRYPTOPHAN HYDROXYLASE;

ADULT; ALLELE; AMYGDALA; ANTERIOR CINGULATE; ARTICLE; BASAL GANGLION; BIOACCUMULATION; BIOSYNTHESIS; BLOOD SAMPLING; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME ACTIVITY; ENZYME SUBSTRATE; FEMALE; GENETIC VARIATION; GENOTYPE; HETEROZYGOTE; HIPPOCAMPUS; HOMOZYGOTE; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REPRODUCIBILITY; SOCIAL PHOBIA; TPH2 GENE; ANXIETY DISORDER; CINGULATE GYRUS; GENETIC POLYMORPHISM; GENETICS; METABOLISM; YOUNG ADULT;

ADULT; ALLELES; AMYGDALA; ANXIETY DISORDERS; BASAL GANGLIA; FEMALE; GENOTYPE; GYRUS CINGULI; HIPPOCAMPUS; HUMANS; MALE; PHOBIA, SOCIAL; POLYMORPHISM, GENETIC; SEROTONIN; TRYPTOPHAN HYDROXYLASE; YOUNG ADULT;

EID: 84988731356     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881116648317     Document Type: Article

References (64)

1. Andersson E, Rück C, Lavebratt C, et al. (2013) Genetic polymorphisms in monoamine systems and outcome of cognitive behavior therapy for social anxiety disorder. PLoS One 8: e79015.
2. Andersson JL, Vagnhammar BE, Schneider H, (1995) Accurate attenuation correction despite movement during PET imaging. J Nucl Med 36: 670-678.
3. Argyropoulos SV, Hood SD, Adrover M, et al. (2004) Tryptophan depletion reverses the therapeutic effect of selective serotonin reuptake inhibitors in social anxiety disorder. Biol Psychiatry 56: 503-509.
4. Arrant AE, Jemal H, Kuhn CM, (2013) Adolescent male rats are less sensitive than adults to the anxiogenic and serotonin-releasing effects of fenfluramine. Neuropharmacology 65: 213-222.
5. Berger M, Gray JA, Roth BL, (2009) The expanded biology of serotonin. Ann Rev Med 60: 355-366.
6. Bergström M, Eriksson L, Bohm C, et al. (1983) Correction for scattered radiation in a ring detector positron camera by integral transformation of the projections. J Comput Assist Tomogr 7: 42-50.
7. 11C-labelled L-tryptophan and 5-hydroxy-L-tryptophan using a multi-enzymatic reaction route. J Chem Soc Perkin Trans 1: 1331-1334.
8. Blanco C, Bragdon LB, Schneier FR, et al. (2013) The evidence-based pharmacotherapy of social anxiety disorder. Int J Neuropsychopharmacol 16: 235-249.
9. Boadle-Biber MC, (1993) Regulation of serotonin synthesis. Prog Biophys Mol Biol 60: 1-15.
10. Booij L, Turecki G, Leyton M, et al. (2012) Tryptophan hydroxylase(2) gene polymorphisms predict brain serotonin synthesis in the orbitofrontal cortex in humans. Mol Psychiatry 17: 809-817.
11. Bordukalo-Niksic T, Mokrovic G, Stefulj J, et al. (2010) 5HT-1A receptors and anxiety-like behaviours: Studies in rats with constitutionally upregulated/downregulated serotonin transporter. Behav Brain Res 213: 238-245.
12. Brown SM, Peet E, Manuck SB, et al. (2005) A regulatory variant of the human tryptophan hydroxylase-2 gene biases amygdala reactivity. Mol Psychiatry 10: 884-888.
13. Brühl AB, Delsignore A, Komossa K, et al. (2014) Neuroimaging in social anxiety disorder-a meta-analytic review resulting in a new neurofunctional model. Neurosci Biobehav Rev 47: 260-280.
14. Canli T, Congdon E, Gutknecht L, et al. (2005) Amygdala responsiveness is modulated by tryptophan hydroxylase-2 gene variation. J Neural Transm (Vienna) 112: 1479-1485.
15. Chen G, Vallender EJ, Miller GM, (2009) Functional characterization of the human TPH2 5′ regulatory region: Untranslated region and polymorphisms modulate gene expression in vitro. Hum Genet 122: 645-657.
16. Chen G-L, Miller GM, (2012) Advances in tryptophan hydroxylase-2 gene expression regulation: New insights into serotonin-stress interaction and clinical implications. Am J Med Genet B Neuropsychiatr Genet 159B: 152-171.
17. David DJP, Bourin M, Jego G, et al. (2003) Effects of acute treatment with paroxetine, citalopram and venlafaxine in vivo on noradrenaline and serotonin outflow: A microdialysis study in Swiss mice. Br J Pharmacol 140: 1128-1136.
18. Drapier D, Bentué-Ferrer D, Laviolle B, et al. (2007) Effects of acute fluoxetine, paroxetine and desipramine on rats tested on the elevated plus-maze. Behav Brain Res 176: 202-209.
19. Durant C, Christmas D, Nutt D, (2010) The pharmacology of anxiety. Curr Top Behav Neurosci 2: 303-330.
20. First MB, Spitzer RL, Gibbon M, et al. (1997) Structured Clinical Interview for DSM-IV Axis I Disorders-Non-Patient Edition. New York: Biometrics Research, New York State Psychiatric Institute.
21. Fisher PM, Meltzer CC, Ziolko SK, et al. (2006) Capacity for 5-HT1A-mediated autoregulation predicts amygdala reactivity. Nat Neurosci 9: 1362-1363.
22. Frick A, Åhs F, Engman J, et al. (2015) Serotonin synthesis and reuptake in social anxiety disorder. JAMA Psychiatry 72: 794-802.
23. Furmark T, Appel L, Henningsson S, et al. (2008) A link between serotonin-related gene polymorphisms, amygdala activity, and placebo-induced relief from social anxiety. J Neurosci 28: 13066-13074.
24. Furmark T, Henningsson S, Appel L, et al. (2009) Genotype over diagnosis in amygdala responsiveness: Affective processing in social anxiety disorder. J Psychiatry Neurosci 34: 30-40.
25. Furmark T, Tillfors M, Garpenstrand H, et al. (2004) Serotonin transporter polymorphism related to amygdala excitability and symptom severity in patients with social phobia. Neurosci Lett 362: 189-192.
26. Geller I, Blum K, (1970) The effects of 5-HTP on para-chlorophenylalanine (p-CPA) attenuation of "conflict" behavior. Eur J Pharmacol 9: 319-324.
27. Gordon JA, Hen R, (2004) The serotonergic system and anxiety. NeuroMol Med 5: 27-40.
28. Graeff FG, Zangrossi H, (2010) The dual role of serotonin in defense and the mode of action of antidepressants on generalized anxiety and panic disorders. Cent Nerv Syst Agents Med Chem 10: 207-217.
29. Gutknecht L, Jacob C, Strobel A, et al. (2007) Tryptophan hydroxylase-2 gene variation influences personality traits and disorders related to emotional dysregulation. Int J Neuropsychopharmacol 10: 309-320.
30. Hagberg GE, Torstenson R, Marteinsdottir I, et al. (2002) Kinetic compartment modeling of [11C]-5-hydroxy-L-tryptophan for positron emission tomography assessment of serotonin synthesis in human brain. J Cereb Blood Flow Metab 22: 1352-1366.
31. Hahn T, Heinzel S, Notebaert K, et al. (2013) The tricks of the trait: Neural implementation of personality varies with genotype-dependent serotonin levels. Neuroimage 81: 393-399.
32. Hale MW, Shekhar A, Lowry CA, (2012) Stress-related serotonergic systems: Implications for symptomatology of anxiety and affective disorders. Cell Mol Neurobiol 32: 695-708.
33. Hermann A, Küpper Y, Schmitz A, et al. (2012) Functional gene polymorphisms in the serotonin system and traumatic life events modulate the neural basis of fear acquisition and extinction. PloS One 7: e44352.
34. Herrmann MJ, Huter T, Müller F, et al. (2007) Additive effects of serotonin transporter and tryptophan hydroxylase-2 gene variation on emotional processing. Cereb Cortex 17: 1160-1163.
35. Hranilovic D, Cicin-Sain L, Bordukalo-Niksic T, et al. (2005) Rats with constitutionally upregulated/downregulated platelet 5HT transporter: Differences in anxiety-related behavior. Behav Brain Res 165: 271-277.
36. Inoue H, Yamasue H, Tochigi M, et al. (2010) Effect of tryptophan hydroxylase-2 gene variants on amygdalar and hippocampal volumes. Brain Res 1331: 51-57.
37. Kessler RC, Berglund P, Demler O, et al. (2005) Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry 62: 593-602.
38. Kim Y-K, Lee H-J, Yang J-C, et al. (2009) A tryptophan hydroxylase 2 gene polymorphism is associated with panic disorder. Behav Genetics 39: 170-175.
39. Lanzenberger RR, Mitterhauser M, Spindelegger C, et al. (2007) Reduced serotonin-1A receptor binding in social anxiety disorder. Biol Psychiatry 61: 1081-1089.
40. Lee BT, Ham BJ, (2008) Serotonergic genes and amygdala activity in response to negative affective facial stimuli in Korean women. Genes Brain Behav 7: 899-905.
41. Lin YMJ, Chao S-C, Chen T-M, et al. (2007) Association of functional polymorphisms of the human tryptophan hydroxylase 2 gene with risk for bipolar disorder in Han Chinese. Arch Gen Psychiatry 64: 1015-1024.
42. Lundquist P, Blomquist G, Hartvig P, et al. (2006) Validation studies on the 5-hydroxy-L-[b-11C]-tryptophan PET method for probing the decarboxylase step in serotonin synthesis. Synapse 59: 521-531.
43. Maldjian JA, Laurienti PJ, Kraft RA, et al. (2003) An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage 19: 1233-1239.
44. Mandelli L, Antypa N, Nearchou FA, et al. (2012) The role of serotonergic genes and environmental stress on the development of depressive symptoms and neuroticism. J Affect Disord 142: 82-89.
45. Maron E, Nutt D, Shlik J, (2012) Neuroimaging of serotonin system in anxiety disorders. Curr Pharm Des 18: 5699-5708.
46. Martin EI, Ressler KJ, Binder E, et al. (2009) The neurobiology of anxiety disorders: Brain imaging, genetics and psychoneuroendocrinology. Psychiatr Clin North Am 32: 549-575.
47. Mattick RP, Clarke JC, (1998) Development and validation of measures of social phobia scrutiny fear and social interaction anxiety. Behav Res Ther 36: 455-470.
48. Mayo-Wilson E, Dias S, Mavranezouli I, et al. (2014) Psychological and pharmacological interventions for social anxiety disorder in adults: A systematic review and network meta-analysis. Lancet Psychiatry 1: 368-376.
49. Mössner R, Walitza S, Geller F, et al. (2006) Transmission disequilibrium of polymorphic variants in the tryptophan hydroxylase-2 gene in children and adolescents with obsessive-compulsive disorder. Int J Neuropsychopharmacol 9: 437-442.
50. Näslund J, Studer E, Pettersson R, et al. (2015) Differences in anxiety-like behaviour within a batch of Wistar rats are associated with differences in serotonergic transmission, enhanced by acute SSRI administration and abolished by serotonin depletion. Int J Neuropsychopharmacol 18: pii: pyv018.
51. Osinsky R, Schmitz A, Alexander N, et al. (2009) TPH2 gene variation and conflict processing in a cognitive and an emotional Stroop task. Behav Brain Res 198: 404-410.
52. Patlak CS, Blasberg RG, Fenstermacher JD, (1983) Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 3: 1-7.
53. Rhodes RA, Murthy NV, Dresner MA, et al. (2007) Human 5-HT transporter availability predicts amygdala reactivity in vivo. J Neurosci 27, 9233-9237.
54. Rotberg B, Kronenberg S, Carmel M, et al. (2013) Additive effects of 5-HTTLPR (serotonin transporter) and tryptophan hydroxylase 2 G-703T gene polymorphisms on the clinical response to citalopram among children and adolescents with depression and anxiety disorders. J Child Adolesc Psychopharm 23: 117-122.
55. Scheuch K, Lautenschlager M, Grohmann M, et al. (2007) Characterization of a functional promoter polymorphism of the human tryptophan hydroxylase 2 gene in serotonergic raphe neurons. Biol Psychiatry 62: 1288-1294.
56. Shin LM, Liberzon I, (2010) The neurocircuitry of fear, stress, and anxiety disorders. Neuropsychopharmacology 35: 169-191.
57. Stein MB, Stein DJ, (2008) Social anxiety disorder. Lancet 371: 1115-1125.
58. Svarer C, Madsen K, Hasselbalch SG, et al. (2005) MR-based automatic delineation of volumes of interest in human brain PET images using probability maps. Neuroimage 24: 969-979.
59. Tancer ME, Mailman RB, Stein MB, et al. (1994) Neuroendocrine responsivity to monoaminergic system probes in generalized social phobia. Anxiety 1: 216-223.
60. Tillfors M, Furmark T, Marteinsdottir I, et al. (2001) Cerebral blood flow in subjects with social phobia during stressful speaking tasks: A PET study. Am J Psychiatry 158: 1220-1226.
61. Walther DJ, Bader M, (2003) A unique central tryptophan hydroxylase isoform. Biochem Pharmacol 66: 1673-1680.
62. Walther DJ, Peter JU, Bashammakh S, et al. (2003) Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science 299: 76.
63. Van der Wee NJ, van Veen JF, Stevens H, et al. (2008) Increased serotonin and dopamine transporter binding in psychotropic medication-naive patients with generalized social anxiety disorder shown by 123I-beta-(4-iodophenyl)-tropane SPECT. J Nucl Med 49: 757-763.
64. Visser AKD, van Waarde A, Willemsen ATM, et al. (2011) Measuring serotonin synthesis: From conventional methods to PET tracers and their (pre)clinical implications. Eur J Nucl Med Mol Imaging 38: 576-591.